Bank of America’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,074,972
Closed -$405M 7768
2019
Q3
$405M Buy
4,074,972
+274,613
+7% +$26.1M 0.06% 306
2019
Q2
$351M Buy
3,800,359
+701,531
+23% +$66.6M 0.05% 335
2019
Q1
$292M Sell
3,098,828
-2,113,604
-41% -$185M 0.05% 358
2018
Q4
$334M Sell
5,212,432
-699,145
-12% -$51.6M 0.06% 313
2018
Q3
$529M Buy
5,911,577
+138,659
+2% +$12.3M 0.08% 252
2018
Q2
$458M Sell
5,772,918
-578,224
-9% -$48M 0.08% 259
2018
Q1
$567M Sell
6,351,142
-1,996,626
-24% -$192M 0.1% 216
2017
Q4
$871M Sell
8,347,768
-4,520,195
-35% -$510M 0.15% 158
2017
Q3
$1.88B Buy
12,867,963
+3,139,662
+32% +$428M 0.3% 77
2017
Q2
$1.26B Sell
9,728,301
-329,748
-3% -$40.4M 0.25% 99
2017
Q1
$1.25B Buy
10,058,049
+321,052
+3% +$38.4M 0.25% 100
2016
Q4
$1.13B Buy
9,736,997
+120,186
+1% +$13.4M 0.24% 99
2016
Q3
$1.01B Sell
9,616,811
-22,146
-0.2% -$2.4M 0.22% 111
2016
Q2
$951M Sell
9,638,957
-242,321
-2% -$25.1M 0.22% 113
2016
Q1
$989M Sell
9,881,278
-1,058,073
-10% -$109M 0.24% 98
2015
Q4
$1.31B Buy
10,939,351
+758,720
+7% +$87.8M 0.31% 68
2015
Q3
$1.1B Buy
10,180,631
+5,155,873
+103% +$640M 0.27% 87
2015
Q2
$582M Sell
5,024,758
-1,803,998
-26% -$206M 0.19% 115
2015
Q1
$787M Buy
6,828,756
+2,019,494
+42% +$241M 0.26% 77
2014
Q4
$538M Sell
4,809,262
-213,631
-4% -$22.5M 0.19% 109
2014
Q3
$476M Sell
5,022,893
-1,178,133
-19% -$106M 0.15% 140
2014
Q2
$533M Sell
6,201,026
-975,356
-14% -$74.2M 0.17% 129
2014
Q1
$501M Buy
7,176,382
+793,598
+12% +$62.8M 0.19% 116
2013
Q4
$539M Buy
6,382,784
+2,020,102
+46% +$160M 0.19% 105
2013
Q3
$336M Buy
4,362,682
+781,176
+22% +$54.7M 0.13% 165
2013
Q2
$209M Buy
+3,581,506
New +$216M 0.09% 212

Other funds holding CELG

Bank of America's CELG Position: Q4 2019 in Review

Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.

Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
  • Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.